Molecular pathogenesis of mantle cell lymphoma, The Journal of clinical investigation, vol.122, 2012. ,
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma, Blood, vol.126, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01543670
Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling, Blood, vol.116, p.953, 2010. ,
The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma, Blood, vol.121, p.3161, 2013. ,
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma, Blood, vol.119, 1963. ,
The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells, Blood, vol.123, p.2988, 2014. ,
Pharmacological and genomic profiling identifies NF-kappaB-targeted treatment strategies for mantle cell lymphoma, Nature medicine, vol.20, 2014. ,
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma, Proceedings of the National Academy of Sciences of the United States of America, vol.110, p.18250, 2013. ,
Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms, Blood, vol.127, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01920364
The 2016 revision of the World Health Organization classification of lymphoid neoplasms, Blood, vol.127, p.2375, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01800015
KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype, Leukemia, vol.29, p.1177, 2015. ,
Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma, Cancer discovery, vol.4, p.1022, 2014. ,
The cancer epigenome: Concepts, challenges, and therapeutic opportunities, Science, vol.355, p.1147, 2017. ,
Role of chromodomain helicase DNA-binding protein 2 in DNA damage response signaling and tumorigenesis, Oncogene, vol.28, p.1053, 2009. ,
Mutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemia, Blood, vol.126, p.195, 2015. ,
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry, The Lancet. Oncology, vol.16, p.1111, 2015. ,
Transcriptional control of early B cell development, Annual review of immunology, vol.22, pp.55-79, 2004. ,
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia, The New England journal of medicine, vol.369, pp.32-42, 2013. ,
Mantle cell lymphoma: evolving management strategies, Blood, vol.125, pp.48-55, 2015. ,
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications, Blood, vol.117, pp.5019-5032, 2011. ,
Models of haematopoiesis: seeing the wood for the trees, Nature reviews Immunology, vol.9, pp.293-300, 2009. ,
Mantle Cell Lymphoma, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.34, p.1256, 2016. ,
The significance of TP53 in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target, British journal of haematology, vol.146, pp.257-269, 2009. ,
Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma, Cancer discovery, vol.4, pp.1022-1035, 2014. ,
Pax5: the guardian of B cell identity and function, Nature immunology, vol.8, pp.463-470, 2007. ,
PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors, Immunity, vol.16, pp.297-309, 2002. ,
Regulation of B lymphocyte and macrophage development by graded expression of PU, Science, vol.1, pp.1439-1441, 2000. ,
CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte, Blood, vol.121, pp.48-53, 2013. ,
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study, Lancet, vol.387, pp.770-778, 2016. ,
Analysis of the chronic lymphocytic leukemia coding, 2011. ,
Haematopoietic cell-fate decisions, chromatin regulation and ikaros, Nature reviews Immunology, vol.2, pp.162-174, 2002. ,
,
, , vol.108, pp.1109-1110, 2006.
The Role of Lymphocytes in the Destruction of Homografts, British medical bulletin, vol.21, pp.106-110, 1965. ,
Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.31, pp.3688-3695, 2013. ,
, , vol.99, pp.15030-15035, 2002.
, America, vol.103, pp.2352-2357, 2006.
, , 2012.
, Laeknabladid, vol.98, pp.585-589
Characterization of FBX25, encoding a novel brain-expressed F-box protein, Biochimica et biophysica acta, vol.1760, pp.110-118, 2006. ,
EBF contains a novel zinc coordination motif and multiple dimerization and transcriptional activation domains, The EMBO journal, vol.14, pp.2907-2916, 1995. ,
Impact of TP53 mutation and 17p deletion in mantle cell lymphoma, Leukemia, vol.25, pp.1904-1908, 2011. ,
EDD mediates DNA damage-induced activation of CHK2, The Journal of biological chemistry, vol.281, pp.39990-40000, 2006. ,
Essential control of early B-cell development by Mef2 transcription factors, Blood, vol.127, pp.572-581, 2016. ,
Improvement of overall survival in advanced stage mantle cell lymphoma, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.27, pp.511-518, 2009. ,
, , 2009.
Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms, Clinical cancer research : an official journal of the American Association for Cancer Research, vol.17, pp.3388-3397, 2011. ,
,
, Hematopoietic lineage-and stage-restricted expression of the ETS oncogene family member PU.1, Blood, vol.82, pp.2998-3004
, , 2008.
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study, Blood, vol.117, pp.1834-1839, 2011. ,
Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics, Nature reviews Cancer, vol.7, pp.750-762, 2007. ,
Molecular pathogenesis of mantle cell lymphoma, The Journal of clinical investigation, vol.122, pp.3416-3423, 2012. ,
Identification of a global gene expression signature of B-chronic lymphocytic leukemia, Molecular cancer research : MCR, vol.1, pp.346-361, 2003. ,
, , 2001.
The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma, Blood, vol.121, pp.3161-3164, 2013. ,
, , 1989.
Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation, The EMBO journal, vol.16, 1997. ,
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma, Nature, vol.476, pp.298-303, 2011. ,
, , 2007.
The E3 ubiquitin ligase EDD regulates S-phase and G(2)/M DNA damage checkpoints, Cell Cycle, vol.6, pp.3070-3077, 2007. ,
Annexe 1 : Classification internationale des maladies pour l'oncologie, troisième édition References 1, Classification of Tumours of Haematopoietic and Lymphoid Tissues ,
, , pp.145-147, 2008.
Clinical and biologic features of CD4(1)CD56(1) malignancies, Blood, vol.99, issue.5, pp.1556-1563, 2002. ,
A combination treatment approach and cord blood stem cell transplant for blastic plasmacytoid dendritic cell neoplasm, Haematologica, vol.98, issue.3, p.36, 2013. ,
,
, Pediatric Diseases, and Acute Leukemia Working Parties. Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation, Blood, vol.121, issue.3, pp.440-446, 2013.
Identification of a leukemic counterpart of the plasmacytoid dendritic cells, Blood, vol.97, issue.10, pp.3210-3217, 2001. ,
Characterization of CD561 dendritic-like cells: a normal counterpart of blastic plasmacytoid dendritic cell neoplasm?, PLoS One, vol.8, issue.11, p.81722, 2013. ,
Agranular CD41 CD561 hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD561 precursor cells related to plasmacytoid monocytes, Am J Surg Pathol, vol.26, issue.7, pp.852-862, 2002. ,
,
Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia ,
, Br J Haematol, vol.145, issue.5, pp.624-636, 2009.
Novel markers of normal and neoplastic human plasmacytoid dendritic cells, Blood, vol.111, issue.7, pp.3778-3792, 2008. ,
Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD41CD561 haematodermic neoplasms and contribute to the aggressiveness of the disease, Leukemia, vol.23, issue.4, pp.698-707, 2009. ,
CD56(1) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique, Blood, vol.99, issue.1, pp.4154-4159, 2002. ,
TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow, Am J Hematol, vol.88, issue.12, pp.1055-1061, 2013. ,
TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm, Br J Haematol, vol.153, issue.3, pp.413-416, 2011. ,
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm, Leukemia, vol.28, issue.4, pp.823-829, 2014. ,
Gene-expression profiling and array-based CGH classify CD41 CD561 hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities, Blood, vol.109, issue.4, pp.1720-1727, 2007. ,
AIRC 5xMille consortium 'Genetics-driven targeted management of lymphoid malignancies' and the Italian Registry on Blastic Plasmacytoid Dendritic Cell Neoplasm. Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition, Leukemia, vol.28, issue.8, pp.1606-1616, 2014. ,
Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited, J Clin Oncol, vol.30, issue.12, pp.1343-1349, 2012. ,
Medical Research Council Adult Leukemia Working Party. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial, Blood, vol.98, issue.5, pp.1312-1320, 2001. ,
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B ,
, Blood, vol.100, issue.13, pp.4325-4336, 2002.
Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS, Nature, vol.523, issue.7559, pp.183-188, 2015. ,
Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS, Cancer Cell, vol.26, issue.4, pp.509-520, 2014. ,
Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling, J Exp Med, vol.212, issue.11, pp.1967-1985, 2015. ,
Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells, J Immunol, vol.176, issue.1, pp.248-255, 2006. ,
URL : https://hal.archives-ouvertes.fr/inserm-00286442
A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma, Int J Hematol, vol.81, issue.2, pp.148-154, 2005. ,
1q12 Chromosome translocations form aberrant heterochromatic foci associated with changes in nuclear architecture and gene expression in B cell lymphoma, EMBO Mol Med, vol.2, issue.5, pp.159-171, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00482580
Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor, Bioinformatics, vol.26, issue.16, pp.2069-2070, 2010. ,
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders, Nat Genet, vol.42, issue.8, pp.722-726, 2010. ,
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia, Br J Haematol, vol.145, issue.6, pp.788-800, 2009. ,
Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers, EMBO Mol Med, vol.5, issue.8, pp.1180-1195, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00852222
An accurate and interpretable model for siRNA efficacy prediction, BMC Bioinformatics, vol.7, p.520, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00433579
Lentiviral vectors and transduction of human cancer B cells, Blood, vol.116, issue.3, pp.498-500, 2010. ,
Identification, characterisation and regulation by CD40 activation of novel CD95 splice variants in CD95-apoptosis-resistant, human, B-cell nonHodgkin's lymphoma, Exp Cell Res, vol.315, pp.3281-3293, 2009. ,
Accurate hematopoietic stem cell frequency estimates by fitting multicell Poisson models substituting to the single-hit Poisson model in limiting dilution transplantation assays, Blood, vol.116, issue.14, pp.2472-2475, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00520297
ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays, J Immunol Methods, vol.347, issue.1-2, pp.70-78, 2009. ,
National Cancer Research Institute Adult Leukaemia Working Group. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials, Blood, vol.116, issue.3, pp.354-365, 2010. ,
The human glucocorticoid receptor: molecular basis of biologic function, Steroids, vol.75, issue.1, pp.1-12, 2010. ,
Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia, Science, 2008. ,
ETV6/ RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling, Blood, vol.117, issue.9, pp.2658-2667, 2011. ,
The genomic landscape of hypodiploid acute lymphoblastic leukemia, Nat Genet, vol.45, issue.3, pp.242-252, 2013. ,
ZEB2 drives immature T-cell lymphoblastic leukaemia online April 8, 2016. ,
,
,
,
, Céline Suchaud-Martin
Els Verhoeyen, Francois-Loic *Corresponding authors, S Rousseaux or S Khochbin, vol.823 ,
The testisspecific double bromodomain-containing protein BRDT forms a complex with multiple spliceosome components and is required for mRNA splicing and 3'-UTR truncation in round spermatids, sophie.rousseaux@ujf-grenoble.fr or Khochbin@ujf-grenoble.fr References Berkovits BD, vol.40, pp.7162-7175, 2012. ,
Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription, Proc Natl Acad Sci, vol.104, pp.13690-13695, 2007. ,
Haploinsufficiency of protamine-1 or -2 causes infertility in mice, Nat Genet, vol.28, pp.82-86, 2001. ,
Insights into role of bromodomain, testis-specific (Brdt) in acetylated histone H4-dependent chromatin remodeling in mammalian spermiogenesis, J Biol Chem, vol.287, pp.6387-6405, 2012. ,
Targeted gene disruption of Hsp70-2 results in failed meiosis, germ cell apoptosis, and male infertility, Proc Natl Acad Sci, vol.93, pp.3264-3268, 1996. ,
You bet-cha: a novel family of transcriptional regulators, Front Biosci, vol.6, pp.1008-1018, 2001. ,
Organismal differences in post-translational modifications in histones H3 and H4, J Biol Chem, vol.282, pp.7641-7655, 2007. ,
From meiosis to postmeiotic events: the secrets of histone disappearance, FEBS J, vol.277, pp.599-604, 2010. ,
The role of histones in chromatin remodelling during mammalian spermiogenesis, Eur J Biochem, vol.271, pp.3459-3469, 2004. ,
Systematic screen reveals new functional dynamics of histones H3 and H4 during gametogenesis, Genes Dev, vol.24, pp.1772-1786, 2010. ,
Pericentric heterochromatin reprogramming by new histone variants during mouse spermiogenesis, J Cell Biol, vol.176, pp.283-294, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00176730
Regulated hyperacetylation of core histones during mouse spermatogenesis: involvement of histone deacetylases, The Histone Code and Beyond, vol.79, pp.950-960, 2000. ,
Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation, J Am Chem Soc, vol.132, pp.9986-9987, 2010. ,
Preparation, isolation and characterization of stage-specific spermatogenic cells for cellular and molecular analysis, Nat Methods, vol.1, pp.249-254, 2004. ,
Cyclin A1 is required for meiosis in the male mouse, Nat Genet, vol.20, pp.377-380, 1998. ,
A highly efficient recombineering-based method for generating conditional knockout mutations, Genome Res, vol.13, pp.476-484, 2003. ,
Small-molecule inhibition of BRDT for male contraception, Cell, vol.150, pp.673-684, 2012. ,
Cooperative binding of two acetylation marks on a histone tail by a single bromodomain, Nature, vol.461, pp.664-668, 2009. ,
URL : https://hal.archives-ouvertes.fr/cea-00909643
Bromodomains as therapeutic targets, Exp Rev Mol Med, vol.13, pp.1-21, 2011. ,
Cyclin A1-deficient mice lack histone H3 serine 10 phosphorylation and exhibit altered aurora B dynamics in late prophase of male meiosis, Dev Biol, vol.306, pp.725-735, 2007. ,
Acetylation-dependent chromatin reorganization by Brdt, a testis-specific bromodomain-containing protein, Mol Cell Biol, vol.23, pp.5354-5365, 2003. ,
Epigenetic reprogramming of the male genome during gametogenesis and in the zygote, Reprod Biomed Online, vol.16, pp.492-503, 2008. ,
The role of human bromodomains in chromatin biology and gene transcription, Curr Opin Drug Discov Dev, vol.12, pp.659-665, 2009. ,
Real-time imaging of histone H4 hyperacetylation in living cells, Proc Natl Acad Sci, vol.106, pp.16257-16262, 2009. ,
Unique chromatin remodeling and transcriptional regulation in spermatogenesis, Science, vol.296, pp.2176-2178, 2002. ,
Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes, J Biol Chem, vol.287, pp.1090-1099, 2012. ,
The first bromodomain of Brdt, a testis-specific member of the BET sub-family of double-bromodomain-containing proteins, is essential for male germ cell differentiation, Development, vol.134, pp.3507-3515, 2007. ,
Identification of unique, differentiation stage-specific patterns of expression of the bromodomain-containing genes Brd2, Brd3, Brd4, and Brdt in the mouse testis, Gene Expr Patterns, vol.4, pp.513-519, 2004. ,
A conditional knockout resource for the genome-wide study of mouse gene function, Nature, vol.474, pp.337-342, 2011. ,
Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification, Cell, vol.146, pp.1016-1028, 2011. ,
) seqMINER: an integrated ChIP-Seq data interpretation platform, Nucleic Acids Res, vol.39, p.35, 2010. ,
Histone acetylation and deacetylation: identification of acetylation and methylation sites of HeLa histone H4 by mass spectrometry, Mol Cell Proteomics, vol.1, pp.500-508, 2002. ,
Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation, Nat Cell Biol, vol.13, pp.1295-1304, 2011. ,